Perrigo Company plc (PRGO)
| Market Cap | 3.46B |
| Revenue (ttm) | 4.37B |
| Net Income (ttm) | -171.80M |
| Shares Out | 136.46M |
| EPS (ttm) | -1.25 |
| PE Ratio | n/a |
| Forward PE | 8.50 |
| Dividend | $1.16 (4.57%) |
| Ex-Dividend Date | Mar 7, 2025 |
| Volume | 848,405 |
| Open | 25.25 |
| Previous Close | 25.14 |
| Day's Range | 25.11 - 25.51 |
| 52-Week Range | 23.14 - 33.46 |
| Beta | 0.49 |
| Analysts | Buy |
| Price Target | 33.00 (+30.08%) |
| Earnings Date | May 6, 2025 |
About PRGO
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain rel... [Read more]
Financial Performance
In 2024, Perrigo Company's revenue was $4.37 billion, a decrease of -6.06% compared to the previous year's $4.66 billion. Losses were -$171.80 million, 1252.8% more than in 2023.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for PRGO stock is "Buy." The 12-month stock price forecast is $33.0, which is an increase of 30.08% from the latest price.
News
Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out
The Trump administration's proposed tariffs on pharmaceuticals have caused significant market turmoil today, with major Pharma stocks plummeting globally. Despite pledges to increase U.S. manufacturin...
Perrigo Company plc (PRGO) 2025 Investor Day (Transcript)
Perrigo Company plc (NYSE:PRGO) Perrigo 2025 Investor Day February 28, 2025 8:00 AM ET Company Participants Brad Joseph - Vice President, Investor Relations Patrick Lockwood-Taylor - President and Ch...
Perrigo Provides Detailed Plan to Consumerize, Simplify and Scale its Unique Global Self-Care Platform at its Virtual Investor Day
DUBLIN, Feb. 28, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that at its Virtual Investor Day, scheduled to begin today at...
31 Upcoming Dividend Increases, Including 3 Kings
This week sees 31 dividend increases, including three Dividend Kings: Genuine Parts, Commerce Bancshares, and Kimberly-Clark, showcasing impressive financial stability and growth. My investment strate...
Perrigo Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing Operations
Making Significant Progress on Stabilizing, Streamlining and Strengthening Organization to Build Long-Term Sustainable, Value Accretive Growth Delivered Fiscal Year 2024 Adjusted EPS of $2.57 the Mid-...
Perrigo to Attend the UBS 2025 Global Consumer and Retail Conference
DUBLIN , Feb. 26, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduar...
Perrigo Increases Quarterly Dividend by 5%
DUBLIN , Feb. 19, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors has approved a 5% increas...
Opill® extends mission of breaking down birth control barriers with launch of multi-state college tour and expansion of partnerships
--WNBA and Opill® continue partnership with Level The Court initiative-- GRAND RAPIDS, Mich. , Feb. 4, 2025 /PRNewswire/ -- Today, Opill®— the first and only daily birth control pill available without...
Perrigo to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 27, 2025, Host Virtual Investor Day on February 28, 2025
DUBLIN, Ireland , Jan. 31, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its fourth quarter and fisca...
Perrigo Paves The Way For Recovery With Margin Focus
Perrigo is a focused OTC consumer healthcare player, slimming down operations and enhancing margins under new management, with a 4.6% dividend yield. Despite short-term pressures from a weak cold-and-...
Perrigo Expands its Scientific Office; Appoints Abbie Lennox as Executive Vice President and Chief Scientific Officer
Expanded Scientific Office Unifies Scientific-Focused Teams, Facilitating Seamless Collaboration Across Product Portfolio Lennox Most Recently Led Regulatory, Medical Affairs, Safety and Quality Teams...
Perrigo Company: Great Combination Of Future Growth With A Low Valuation
Perrigo's long-term growth is driven by strategic initiatives like Project Energize, aiming for $140-$170 million in annualized savings by 2026. The company's reinvestments in leadership and IT, addin...
Perrigo Company plc (PRGO) Q3 2024 Earnings Call Transcript
Perrigo Company plc (NYSE:PRGO) Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ET Company Participants Bradley Joseph - Vice President of Global Investor Relations Patrick Lockwood-Taylor ...
Perrigo Reports Third Quarter 2024 Financial Results From Continuing Operations
Company Delivered Solid Third Quarter Financial Results, Including Meaningful Operating Income Growth and Margin Expansion Infant Formula Business Recovery Making Significant Progress, Including Perri...
Perrigo Announces Quarterly Dividend
DUBLIN , Nov. 1, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly divid...
Perrigo to Release Third Quarter 2024 Financial Results on November 6, 2024
DUBLIN , Oct. 23, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its third quarter 2024 financial resu...
WNBA Star Napheesa Collier Joins Team Opill® for Candid Conversations on Women's Health
Opill® and Collier will hit the road to talk to women about their reproductive health options. GRAND RAPIDS, Mich.
Perrigo Announces Good Start® and Dr. Browns® Brand Partnership and Launch of Infant Formula Portfolio
DUBLIN , Sept. 26, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced a new brand partnership: Good Start®1 and Dr. Brown'...
PERRIGO ANNOUNCES THE CLOSING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY
DUBLIN , Sept. 17, 2024 /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO) today announced the closing of a registered public offering by Perrigo Finance Unlimited Company, ...
PERRIGO ANNOUNCES THE PRICING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY
DUBLIN , Sept. 12, 2024 /PRNewswire/ -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO) today announced the pricing of a registered public offering by Perrigo Finance Unlimited Company, ...
Perrigo Appoints Industry Veteran, Charles Atkinson, as Executive Vice President, General Counsel and Secretary
Atkinson joins Perrigo from Haleon plc, where he previously served as Interim General Counsel DUBLIN , Sept. 4, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Cons...
Perrigo to Attend the Piper Sandler Growth Frontiers Conference
DUBLIN , Aug. 27, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduar...
Perrigo Appoints David Ball to the Newly Created Position of Executive Vice President and Chief Brand and Digital Officer
DUBLIN , Aug. 19, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced the appointment of Dr. David Ball as Executive Vice P...
Perrigo is voluntarily recalling 16,500 cans of baby formula because of high levels of Vitamin D
Perrigo Co. Plc PRGO, +0.54% said Friday it's voluntarily recalling 16,500 cans of store brand Premium Infant Formula with iron milk-based powder because of levels of Vitamin D that exceed permitted l...
Perrigo recalls 16,500 cans of its infant formula
Perrigo has initiated a voluntary recall of three lots within one batch, or 16,500 cans, of its infant formula sold at H-E-B Grocery Company and CVS , a regulatory filing showed on Friday.